Health
Novel microfluidic approach to fight cancer could greatly benefit patients – News-Medical.Net
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technolo…
Reviewed by Emily Henderson, B.Sc.Oct 20 2020
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technology to “purify” the immune cells of patients in the fight against cancer.
UniSA’s Future Industries Institute PhD student Mona Elsemary has developed a microfluidic approach to purify chimeric antigen receptor (CAR-T) cells, the bioengineered immune cells that are the basis of groundbreaking …
-
Noosa News15 hours agoMitch Power Quick Shear event gets men talking about mental health
-
Noosa News18 hours agoRaising your voice | Noosa Today
-
General16 hours agoAccused of Antisemitism: Herald Sun, Israel lobby v Dandenong Clr Rhonda Garad
-
Noosa News9 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs